261 related articles for article (PubMed ID: 15722070)
21. Pharmacokinetics of single-dose levonorgestrel in adolescents.
Sambol NC; Harper CC; Kim L; Liu CY; Darney P; Raine TR
Contraception; 2006 Aug; 74(2):104-9. PubMed ID: 16860047
[TBL] [Abstract][Full Text] [Related]
22. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
[TBL] [Abstract][Full Text] [Related]
23. Population-based evaluation of the effectiveness of two regimens for emergency contraception.
Leung VW; Soon JA; Lynd LD; Marra CA; Levine M
Int J Gynaecol Obstet; 2016 Jun; 133(3):342-6. PubMed ID: 26969148
[TBL] [Abstract][Full Text] [Related]
24. Effects of ABT-761, a novel 5-lipoxygenase inhibitor, on the pharmacokinetics of a single dose of ethinyl estradiol and levonorgestrel in healthy female volunteers.
Wong SL; O'Dea RF; Dube LM; Awni WM
J Clin Pharmacol; 1998 Jul; 38(7):642-8. PubMed ID: 9702850
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the pharmacokinetic profile of an ascending-dose, extended-regimen combined oral contraceptive to those of other extended regimens.
Darwish M; Bond M; Ricciotti N; Hsieh J; Fiedler-Kelly J; Grasela T
Reprod Sci; 2014 Nov; 21(11):1401-10. PubMed ID: 24647707
[TBL] [Abstract][Full Text] [Related]
26. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO
Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593
[TBL] [Abstract][Full Text] [Related]
27. Comparative pharmacokinetics of levonorgestrel and ethinyloestradiol following intravenous, oral and vaginal administration.
Back DJ; Grimmer SF; Rogers S; Stevenson PJ; Orme ML
Contraception; 1987 Oct; 36(4):471-9. PubMed ID: 3127114
[TBL] [Abstract][Full Text] [Related]
28. [Transdermal contraception--a new beginning].
Sigridov I; Dikov I; Ivanov S
Akush Ginekol (Sofiia); 2004; 43 Suppl 1():19-27. PubMed ID: 15323313
[No Abstract] [Full Text] [Related]
29. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
Trapnell CB; Donahue SR; Collins JM; Flockhart DA; Thacker D; Abernethy DR
Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424
[TBL] [Abstract][Full Text] [Related]
30. Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women.
Sivasubramanian R; Chakraborty A; Rouzade-Dominguez ML; Neelakantham S; Jakab A; Mensinga T; Legangneux E; Woessner R; Ufer M
Int J Clin Pharmacol Ther; 2015 Jul; 53(7):550-6. PubMed ID: 25943176
[TBL] [Abstract][Full Text] [Related]
31. New company plans progestin-only ECP.
Contracept Technol Update; 1998 Nov; 19(11):143-5. PubMed ID: 12294210
[TBL] [Abstract][Full Text] [Related]
32. Emergency postcoital contraception.
Wertheimer RE
Am Fam Physician; 2000 Nov; 62(10):2287-92. PubMed ID: 11126855
[TBL] [Abstract][Full Text] [Related]
33. Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study.
Johnson-Agbakwu C; Brown L; Yuan J; Kissling R; Greenblatt DJ
Clin Ther; 2018 Jan; 40(1):64-73. PubMed ID: 29198449
[TBL] [Abstract][Full Text] [Related]
34. Bioavailability study with 2 different levonorgestrel-containing drugs in women.
Nassr N; Farker K; Lautenschlager M; Nagel U; Zimmermann H; Mellinger U; Hoffmann A
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):123-7. PubMed ID: 9089002
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of a single oral dose of 1.5-mg levonorgestrel when administered as 750-mug tablets or as 30-microg minipills.
Devoto L; Espinoza A; Muñoz A; Fuentes A; von Hertzen H
Fertil Steril; 2007 Oct; 88(4):976-7. PubMed ID: 17481615
[TBL] [Abstract][Full Text] [Related]
36. Nasal delivery of levonorgestrel for contraception: an experimental study in rats.
Shahiwala A; Misra A
Fertil Steril; 2004 Mar; 81 Suppl 1():893-8. PubMed ID: 15019826
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol for contraception and control of menstrual symptoms.
Jensen JT; Archer DF
Expert Opin Pharmacother; 2008 Feb; 9(2):319-27. PubMed ID: 18201154
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
Archer DF; Jensen JT; Johnson JV; Borisute H; Grubb GS; Constantine GD
Contraception; 2006 Dec; 74(6):439-45. PubMed ID: 17157099
[TBL] [Abstract][Full Text] [Related]
39. A randomized trial to compare 24 h versus 12 h double dose regimen of levonorgestrel for emergency contraception.
Ngai SW; Fan S; Li S; Cheng L; Ding J; Jing X; Ng EH; Ho PC
Hum Reprod; 2005 Jan; 20(1):307-11. PubMed ID: 15567882
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and adhesion of the Agile transdermal contraceptive patch (AG200-15) during daily exposure to external conditions of heat, humidity and exercise.
Archer DF; Stanczyk FZ; Rubin A; Foegh M
Contraception; 2013 Feb; 87(2):212-9. PubMed ID: 23158806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
